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Purpose: Assessing treatment satisfaction can guide speciﬁc interventions to improve
anticoagulation adherence and reduce adverse outcomes. We aimed to assess the psycho-
metric properties (reliability and validity) of the Maltese translation of the Duke
Anticoagulation Satisfaction Scale (DASS).
Patients and methods: The DASS explores three dimensions (limitations, hassles/bur-
dens, psychological impact). The translation process included forward and backward transla-
tions. Reliability was evaluated through internal consistency and reproducibility. Validity was
evaluated through ﬂoor/ceiling effect, convergent/discriminant validity, construct validity,
and known-group validity.
Results: The Maltese version of the DASS, administered to 174 patients on warfarin for
different clinical indications, showed good reliability (Cronbach’s alpha 0.87; intraclass
correlation coefﬁcient for test–retest 0.73). Floor effect was identiﬁed mainly in the limita-
tions and hassles/burdens subscales. Signiﬁcant positive correlations were found between the
DASS total score and its subscales (limitations 0.80, hassles/burdens 0.85, psychological
impact 0.68). Female sex, shorter warfarin treatment duration (≤5 years), previous hospita-
lization and history of bleeding were associated with lower satisfaction.
Conclusion: Psychometric properties of the Maltese DASS were comparable to the original
English version. The Maltese version of the DASS is a valid and reliable instrument that can
be used by health care professionals to assess the level of satisfaction of Maltese-speaking
anticoagulated patients.
Keywords: atrial ﬁbrillation, psychometrics, quality of life, surveys and questionnaires,
venous thromboembolism, warfarin
Introduction
As anticoagulant therapy is a chronic treatment for most clinical indications, it can
affect patients’ quality of life and satisfaction.1–3 Vitamin K antagonists (VKA) are
one of the oral anticoagulant medications currently available for the treatment and
secondary prevention of venous thromboembolism (VTE) and for stroke prevention
in patients with atrial ﬁbrillation (AF).4 VKAs require routine laboratory monitor-
ing in order to maintain the international normalized ratio (INR) within the ther-
apeutic target range and have several food/drug restrictions, therefore contributing
to the burden of these medications.2,4
Health-related quality of life (QoL) is an important aspect in the decision-making
process and can be measured through the use of generic scales and condition-speciﬁc
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scales. Generic scales, e.g., the 36-item Short Form5 or the
12-item Short Form,6 can be applied to patients with differ-
ent conditions, such as rheumatological, orthopedic and
hematological diseases.7–9 Speciﬁc scales measure aspects
of QoL that are related to a particular condition, for
instance, the Duke Anticoagulation Satisfaction Scale
(DASS) and the Perception of Anticoagulant Treatment
Questionnaire (PACT-Q) measure the QoL of anticoagu-
lated patients.10,11 Understanding the degree of satisfaction
associated with the anticoagulant treatment allows for spe-
ciﬁc interventions to focus on increasing the anticoagula-
tion adherence and reduce adverse clinical outcomes.
However, there was no such scales assessing the satisfaction
of anticoagulated patients that had been validated in the
Maltese language.
We chose to translate the DASS and the PACT-Q
because they have been used in several studies enrolling
patients with various clinical indications to the anticoagu-
lant treatment.10,12–19 The aim of this study was to assess
the psychometric properties (reliability and validity) of the
Maltese version of the DASS. The psychometric properties
of the Maltese version of the PACT-Q have been reported
in a separate paper.20
Materials and methods
The DASS
The DASS explores three dimensions: limitations (9 items),
hassles and burdens (8 items) and psychological impact
(5 positive items and 3 negative items).10 Therefore, the
DASS has 25 items, each with 7 possible responses (not at
all, a little, somewhat, moderately, quite a bit, a lot, and very
much). Six items require reverse-coding prior to analysis. The
ﬁnal score can range from 25 to 175, with lower scores
representing greater satisfaction and less hassles and
burdens.10
Permission to translate and use the DASS was obtained
from the corresponding author of the original DASS
paper.10 According to published guidelines,21,22 different
people, all bilingual in English and Maltese (a professional
translator, a health psychologist, and a speech and lan-
guage pathologist), were involved in the translations of
the DASS, with two forward translations from English to
Maltese and a backward translation from Maltese to
English. For the pilot testing of the Maltese version of
the DASS, the questionnaire was completed and discussed
with 5 patients on long-term oral anticoagulant treatment
(not included in this analysis).
Study population
The Maltese version of the DASS was completed by 174
patients on warfarin treatment for different clinical indica-
tions, enrolled from the Anticoagulation Clinics at 5 Health
Centres (Cospicua, Floriana, Mosta, Qormi, Rabat) and at
Mater Dei Hospital (Msida) in Malta. INR testing at the
Health Centres is performed using point-of-care devices,
while at Mater Dei Hospital is performed using traditional
venepuncture. In both settings, warfarin dose adjustment is
decided by the attending physicians. Patients with cognitive
impairment, dementia or major psychiatric disorders (such
as schizophrenia) were excluded.
The questionnaires were distributed by two authors (NR,
CBX) between July 2017 and February 2018 and patients were
also asked to ﬁll in a form on sociodemographic data (age, sex,
living situation, level of education, working status, and self-
reported history of any bleeding). Questionnaires were identi-
ﬁed using a code, to ensure anonymity. The researchers had the
list with the correspondence between the code and the demo-
graphic details, which was used to contact the patients only in
case of missing values. Therefore, there were no missing
answers in our cohort. From a review of clinical notes, we
also collected information on clinical indication and duration
of the anticoagulant treatment, INR on the day of enrollment,
INR results and any hospitalization in the previous year.
For the purpose of this validation study, we also con-
sidered 157 patients who completed the English version of
the DASS, enrolled from the same Anticoagulation Clinics
during the same time frame. Malta is a bilingual country,
where Maltese is the national language and English is
considered a co-ofﬁcial language.23 The choice of whether
to complete the Maltese or the English version of the
DASS was left at the discretion of each patient.
A randomly chosen sample of 40 patients was retested
after 7–14 days: 20 patients who initially completed the
Maltese version and 20 patients who initially completed the
English version. Half of each group was retested in the same
language (to estimate the intra-language correlation), while
the other half was retested in the other language (to estimate
the cross-language correlation).
This study was approved by the University of Malta
Research and Ethics Committee (Ref No 07/2016) and all
patients signed an informed consent form before inclusion.
Statistical analysis
Continuous variables were expressed as mean ± SD and
compared using the Student’s independent samples t-test;
Riva et al Dovepress
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categorical variables were expressed as counts and percen-
tages and compared using the Chi-square or the Fisher’s
exact tests, as appropriate.
For the calculation of the DASS score, six items (3h, 4a,
4b, 4f, 4h and 4j) were reverse-coded, as reported in the
original publication.10
Reliability of the Maltese version of the DASS was
evaluated through internal consistency and reproducibility.24
The internal consistency (correlation between different items
on the same scale or subscale) was assessed using the
Cronbach’s alpha coefﬁcient, with a value ≥0.70 considered
acceptable.25
Reproducibility was assessed in the subgroup of
patients who participated in the test–retest in the same
language and the intraclass correlation coefﬁcients (ICC)
were calculated (intra-language correlation for the
Maltese–Maltese test–retest and the English–English
test–retest). Commonly cited cut-off for ICC considers
acceptable values between 0.60 and 0.74.26 We evaluated
the cross-language test–retest correlation in those patients
who participated in the test–retest in the other language.
We calculated the raw cross-language correlation and the
adjusted cross-language correlation (adjusted for score
unreliability by dividing the raw cross-language test–retest
correlation by the square-root of the product of the
Maltese–Maltese and English–English test–retest intra-lan-
guage correlation).27,28 For the cross-language correlation,
the English–Maltese and Maltese–English test–retest
groups were pooled together, as previously done.28
Validity of the Maltese version of the DASS was
evaluated through ﬂoor and ceiling effect, convergent
and discriminant validity, construct validity, and known-
group validity. Floor effect occurs when a signiﬁcant pro-
portion of respondents (>15%) achieves the lowest score;
vice versa, ceiling effect occurs when a signiﬁcant propor-
tion of respondents (>15%) achieves the highest score,
meaning that there is more variance that the questionnaire
is able to capture (limited content validity).29
Convergent and discriminant validity was assessed
through factor analysis. An exploratory factor analysis
with varimax rotation was performed to examine the struc-
ture of the DASS. In the conﬁrmatory factor analysis the
following parameters were calculated: root mean square
error of approximation (RMSEA), where values ≤0.05
correspond to “good ﬁt,” and values ≤0.08 correspond to
“acceptable ﬁt”; standardized root mean squared residual
(SRMR), where values ≤0.05 correspond to “good ﬁt,” and
values ≤0.10 correspond to “acceptable ﬁt”; goodness-of-
ﬁt index (GFI), adjusted goodness-of-ﬁt index (AGFI) and
comparative ﬁt index (CFI), where values ≥0.90 are con-
sidered “acceptable ﬁt.”30
Construct validity was evaluated by assessing the
Pearson’s correlation between different subscales and
between each subscale and the overall DASS (scale-subscale
validity).31
Known-group validity was evaluated by assessing the
correlation (Pearson’s or point-biserial correlation as appro-
priate) between the overall DASS score and the following
covariates, some of which have been previously shown to
correlate with patients’ satisfaction10,12,13,32,33: increasing
age; male sex; living alone; level of education primary school
only; full-time or part-time paid employment; AF as clinical
indication to anticoagulant treatment; warfarin treatment
duration >5 years; INR in range at enrollment; high time
within therapeutic range (TTR ≥70%, calculated according to
the Rosendaal method34) in the previous 12 months; any
hospitalization in the previous 12 months; self-reported his-
tory of any bleeding on warfarin.
We planned a sample size of at least 150 patients, given
that published recommendations considered adequate a
sample size of at least 50 patients29 and that previous
validation studies enrolled approximately 100 patients.35,36
Statistical analysis was performed using the statistical soft-
ware STATA SE v.12 (StataCorp LP, College Station, TX,
USA) and SAS v. 9.4 (SAS Institute Inc, Cary, NC, USA),
with two-tailed P<0.05 considered statistically signiﬁcant.
Results
Study population
Baseline characteristics of the enrolled patients, including
sociodemographic details, are reported in Table 1. The com-
parison between patients who completed the Maltese and the
English version of the DASS showed some differences: there
was a predominance of female (P=0.01) and primary school
level of education (P<0.001) among those subjects who
completed the Maltese version of the DASS; while full- or
part-time employment (P<0.001) and heart valve replace-
ment as indication to warfarin (P=0.02) were more common
among those subjects who completed the English version of
the DASS. While the overall DASS score was similar in the
two cohorts, patients who completed the Maltese version
obtained higher scores in the psychological impact subscale
(mean ± SD 23.4±6.2 for the Maltese version vs 21.3±7.4 for
the English version, P=0.006), corresponding to lower antic-
oagulation satisfaction.
Dovepress Riva et al
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Table 1 Baseline characteristics of the study population
Patients who completed the
Maltese questionnaire (n=174)
Patients who completed the
English questionnaire (n=157)
P-value
Age (years), mean (SD) 70 (10.1) 69.8 (10.2) 0.87
Females, n (%) 92 (52.9) 61 (38.9) 0.01
Living situation, n (%) 0.82
Living with family members 138 (79.3) 124 (79.0)
Living alone 31 (17.8) 30 (19.1)
Other 5 (2.9) 3 (1.9)
Level of education, n (%) <0.001
Primary school 108 (62.1) 36 (22.9)
Secondary school 48 (27.6) 67 (42.7)
College or above 18 (10.3) 54 (34.4)
Employment status, n (%) <0.001
Full-time or part-time paid employment 18 (10.3) 25 (15.9)
Retired/pension 103 (59.2) 114 (72.6)
Other (homemaker/housewife, unemployed) 53 (30.5) 18 (11.5)
Clinical indications to warfarin, n (%)a
Atrial ﬁbrillation 122 (70.1) 97 (61.8) 0.11
Venous thromboembolism 30 (17.2) 23 (14.7) 0.52
Heart valve replacement 25 (14.4) 38 (24.2) 0.02
Other 25 (14.4) 9 (5.7) 0.32
Warfarin treatment duration, n (%) 0.15
≤5 years 98 (56.3) 76 (48.4)
>5 years 76 (43.7) 81 (51.6)
INR at enrollment, n (%) 0.31
In range 99 (56.9) 98 (62.4)
Other (above or below range) 75 (43.1) 59 (37.6)
High TTR (≥70%) in the previous year, n (%)b 96 (56.5) 89 (59.7) 0.56
Any hospitalisation in the previous year, n (%)b 86 (50.6) 77 (51.7) 0.85
Self-reported history of any bleeding, n (%) 63 (36.2) 50 (31.9) 0.40
Site of enrollment, n (%) 0.96
Health centers 86 (49.4) 78 (49.7)
Mater Dei Hospital 88 (50.6) 79 (50.3)
DASS results, mean (SD)
Overall score 56.7 (18.5) 53.6 (16.9) 0.18
Limitations subscale 17.1 (9.4) 17.0 (8.0) 0.92
Hassles/burdens subscale 16.2 (8.0) 15.3 (6.7) 0.27
Psychological impact subscale 23.4 (6.2) 21.3 (7.4) 0.006
Notes: aMore than one option is possible. bData available only in 170 patients who completed the Maltese version and 149 patients who completed the English version.
Abbreviations: INR, international normalized ratio; TTR, time within therapeutic range; DASS, Duke Anticoagulation Satisfaction Scale.
Riva et al Dovepress
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Internal consistency
The internal consistency of the Maltese translation of the
DASS was good with the following Cronbach’s alpha coefﬁ-
cients: 0.87 for the overall DASS total score; 0.86 for the
limitations subscale (9 items); 0.84 for the hassles and bur-
dens subscale (8 items); 0.65 for the positive (5 items) and
0.64 for the negative (3 items) psychological impact sub-
scales. When the 8 items of the psychological impact sub-
scale were considered together, Cronbach’s alpha was 0.57.
The English version of the DASS also shows good internal
consistency in our cohort: overall DASS Cronbach’s alpha
0.85; limitations subscale 0.82; hassles and burdens subscale
0.79; positive psychological impact 0.79; negative psycholo-
gical impact 0.56; overall psychological impact 0.71.
Details of the internal consistency analysis are reported
in Table 2. No signiﬁcant increase or decrease of the
Cronbach’s alpha coefﬁcients was observed when each
question was deleted.
Reproducibility
ICC for the intra-language correlation was very good,
being 0.73 for the DASS total score in the Maltese–
Maltese test–retest and 0.85 in the English–English test–
retest. Further details of the intra-language correlation,
including DASS subscales, are reported in Table S1.
ICC for the cross-language correlation for the DASS
total score was 0.31 and the adjusted cross-language cor-
relation was 0.39. When analyzed separately, ICC for the
English–Maltese test–retest was 0.59, while ICC for the
Maltese–English test–retest was 0.
Floor and ceiling effect
When we analyzed the response distribution for each item
of the Maltese translation of the DASS, a signiﬁcant ﬂoor
effect was identiﬁed, mainly in questions pertaining to the
limitations and hassles/burdens subscales (Table 3).
Except for one question, no signiﬁcant ceiling effect was
detected. However, a signiﬁcant ﬂoor effect was observed
also in the English version of the DASS in our study
(Table S2) and in the original publication of the DASS.10
We subsequently analyzed the results of the overall
DASS score and each subscale. In the Maltese version
ﬂoor effect was 0% for the overall DASS, 15.5% for limita-
tions, 3.5% for hassles/burdens, and 0% for psychological
impact (1.2% for positive and 12.1% for negative psycho-
logical impact). In the English version ﬂoor effect was 0%
for the overall DASS, 12.1% for limitations, 14.7% for
hassles/burdens, and 1.9% for psychological impact (6.4%
for positive and 14.0% for negative psychological impact).
Ceiling effect was 0% for all subscales in both languages.
Factor analysis
Results of the conﬁrmatory factor analysis were unsatis-
factory. For the Maltese version of the DASS, RMSEA
and SRMR (both 0.13) were slightly above the acceptable
value (≤0.08 and ≤0.10, respectively); whereas GFI (0.64),
AGFI (0.57) and CFI (0.67) were all below the adequate ﬁt
level (≥0.90). However, we obtained similar unsatisfactory
results for the English version of the DASS in our study
cohort: RMSEA 0.10, SRMR 0.14, GFI 0.66, AGFI 0.65,
CFI 0.63. Detailed results of the factor analysis and the
rotated factor pattern, in comparison to previously pub-
lished studies,10,13 is reported in Table 4.
Correlation scale-subscales
We found a statistically signiﬁcant positive correlation
between the DASS total score and its main subscales.
For the Maltese version correlation coefﬁcients were 0.80
for limitations, 0.85 for hassles and burdens, and 0.68 for
psychological impact. For the English version correlation
coefﬁcients were 0.74, 0.82, and 0.74, respectively. Details
of the correlation between each subscale are reported in
Table S3.
Known-group validity
The Maltese version of the DASS showed a signiﬁcant
positive correlation with previous hospitalization and pre-
vious bleeding events, a signiﬁcant negative correlation
with longer anticoagulant treatment duration, and a border-
line negative correlation with male sex. These ﬁndings sug-
gest that female sex, shorter treatment duration (≤5 years),
previous hospitalization and history of bleeding are asso-
ciated with lower satisfaction.
The English version of the DASS showed a signiﬁcant
negative correlation with increasing age and male sex, and
a signiﬁcant positive correlation with paid-employment
status and previous bleeding. These ﬁndings suggest that
young age, female sex, full- or part-time paid employment
and history of bleeding are associated with lower
satisfaction.
However, for all the signiﬁcant sociodemographic
and clinical characteristics the correlation with the
DASS total score was in the same direction for both
languages, although sometimes lacking of statistical sig-
niﬁcance (Table 5).
Dovepress Riva et al
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Discussion
In our study, for theﬁrst time, theDASSwas translated into the
Maltese language and we administered this questionnaire to a
group of patients on warfarin treatment for different clinical
indications. We evaluated the reliability and the validity of the
Maltese translation in comparison to the psychometric proper-
ties of the DASS previously reported in the literature and to the
original English version completed by a different group of
patients in our study cohort. We found that the Maltese
DASS has good reliability and an acceptable level of validity.
Table 2 Internal consistency of the Maltese and English versions of the DASS in our study cohort
DASS Item Maltese version English version
Cronbach’s
alpha
coefﬁcient
Item-total
correlation
Cronbach’s
alpha if item
deleted
Cronbach’s
alpha
coefﬁcient
Item-total
correlation
Cronbach’s
alpha if item
deleted
DASS score
(overall)
0.87 0.85
Limitations subscale 0.86 0.82
1a 0.60 0.85 0.54 0.79
1b 0.63 0.85 0.59 0.79
1c 0.72 0.84 0.48 0.80
1d 0.70 0.84 0.63 0.79
1e 0.72 0.84 0.66 0.78
2a 0.46 0.86 0.46 0.80
2b 0.31 0.88 0.43 0.81
2c 0.60 0.85 0.47 0.81
2d 0.70 0.84 0.56 0.79
Hassles/burdens
subscale
0.84 0.79
3a 0.59 0.82 0.51 0.76
3b 0.73 0.80 0.61 0.74
3c 0.70 0.81 0.57 0.75
3d 0.48 0.83 0.66 0.74
3e 0.80 0.79 0.70 0.73
3f 0.56 0.82 0.38 0.78
3g 0.78 0.79 0.74 0.73
3h 0.004 0.88 0.12 0.86
Psychological
impact (positive)
subscale
0.65 0.79
4a 0.34 0.63 0.60 0.74
4b 0.54 0.55 0.69 0.72
4f 0.38 0.65 0.49 0.79
4h 0.48 0.59 0.60 0.75
4j 0.42 0.59 0.55 0.76
Psychological
impact (negative)
subscale
0.64 0.56
4d 0.41 0.62 0.39 0.45
4g 0.55 0.40 0.45 0.33
4i 0.41 0.59 0.30 0.56
Abbreviation: DASS, Duke Anticoagulation Satisfaction Scale.
Riva et al Dovepress
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The internal consistency was very good, with
Cronbach’s alpha coefﬁcients for the overall DASS
score and the subscales limitations and hassles/burdens
above 0.80. The Cronbach’s alpha coefﬁcients were
slightly below the acceptable cut-off for the positive
and negative psychological impact subscales (0.65 and
0.64, respectively). However, lower coefﬁcients were
reported in another study evaluating the Brazilian-
Portuguese version of the DASS (0.67 and 0.38,
respectively)13 and in the English version in our study
cohort (0.79 and 0.56, respectively). The low number of
items included in these two subscales (5 questions in the
positive impact and 3 questions in the negative impact)
might be contributing to this ﬁnding.
Test–retest reliability (intra-language correlation) of
the DASS in our cohort was very good with an ICC of
0.73 for the Maltese version and 0.85 for the English
version, which are above the desirable cut-off and similar
to values reported in the literature.10,32 Given the
peculiarity of the Maltese population with high percentage
of bilingual subjects,37 we were also able to assess the
cross-language correlation. Despite the rigorous process of
translation, the ICC for the cross-language correlation was
lower than the ICC for the intra-language correlation.
However, this ﬁnding has been previously reported by
several authors27,38 and different solutions have been pro-
posed. Wood et al hypothesized that it could be due to
score unreliability and suggested to adjust the cross-lan-
guage correlation by the intra-language correlation,27
while Chung et al hypothesized that it could be due to
poor bilingual proﬁciency and performed a sub-analysis of
subjects with higher level of education.38 In agreement
with the study by Wood et al,27 we obtained better cross-
language correlation when applying the suggested adjust-
ment. In our study, the number of retested patients with
higher level of education was too low to perform a speciﬁc
sub-analysis. However, when we analyzed separately the
English–Maltese and Maltese–English test–retest, we
Table 3 Response distribution for each DASS item of the Maltese translation and summary statistics
DASS
item
Response category (%) Mean (SD) in our
study (Maltese
version)
Mean (SD) in our
study (English
version)
Mean (SD) in the
study by Samsa et
al10
1 2 3 4 5 6 7
1a 74.1 13.2 1.7 3.5 4.0 2.9 0.6 1.61 (1.31) 1.59 (1.28) 1.84 (1.37)
1b 75.9 12.1 3.5 2.9 1.7 3.5 0.6 1.55 (1.25) 1.50 (1.12) 1.36 (0.99)
1c 60.3 16.1 6.3 2.9 4.6 6.3 3.5 2.08 (1.76) 2.04 (1.51) 1.69 (1.36)
1d 76.4 12.6 2.3 2.3 1.7 3.5 1.2 1.55 (1.30) 1.46 (1.14) 1.84 (1.78)
1e 72.4 12.6 3.5 5.8 1.2 3.5 1.2 1.66 (1.35) 1.62 (1.19) 1.88 (1.31)
2a 39.1 24.7 13.2 9.8 8.1 4.6 0.6 2.39 (1.54) 2.10 (1.35) 2.60 (1.66)
2b 70.1 13.2 2.3 4.6 2.3 4.6 2.9 1.81 (1.60) 2.14 (1.59) 1.97 (1.89)
2c 46.6 19.5 10.9 4.0 9.2 5.8 4.0 2.43 (1.82) 2.71 (1.96) 3.02 (2.12)
2d 55.2 20.1 8.1 8.1 2.3 4.0 2.3 2.03 (1.55) 1.86 (1.21) 2.20 (1.43)
3a 63.2 17.8 5.8 5.2 2.3 4.0 1.7 1.84 (1.47) 1.80 (1.19) 1.78 (1.22)
3b 46.6 19.0 9.8 11.5 4.6 5.8 2.9 2.37 (1.72) 2.15 (1.49) 2.09 (1.25)
3c 62.1 20.1 5.2 6.3 3.5 2.9 0.0 1.78 (1.29) 1.66 (1.16) 1.65 (1.09)
3d 74.1 10.3 5.2 2.9 4.0 3.5 0.0 1.63 (1.30) 1.78 (1.08) 1.76 (0.97)
3e 57.5 16.1 7.5 6.3 5.2 6.3 1.2 2.09 (1.64) 1.85 (1.35) 1.76 (1.24)
3f 69.0 14.4 7.5 3.5 4.6 0.6 0.6 1.64 (1.20) 1.33 (0.90) 1.37 (0.90)
3g 52.3 23.0 5.8 7.5 5.2 5.2 1.2 2.10 (1.57) 1.94 (1.19) 1.81 (1.17)
3h 7.5 52.3 23.0 5.2 4.0 4.6 3.5 2.74 (1.39) 2.77 (1.98) 2.90 (2.19)
4a 4.0 31.6 30.5 16.7 4.6 10.3 2.3 3.26 (1.44) 2.54 (1.50) 2.32 (1.67)
4b 4.0 40.2 28.2 17.2 4.0 4.6 1.7 2.98 (1.26) 2.64 (1.46) 2.78 (1.66)
4d 20.7 15.5 10.9 18.4 14.9 14.9 4.6 3.55 (1.89) 2.87 (1.77) 2.55 (1.64)
4f 7.5 19.0 12.1 10.3 8.6 14.9 27.6 4.49 (2.12) 4.01 (2.01) 4.15 (2.08)
4g 58.7 14.9 6.9 9.2 4.6 5.2 0.6 2.04 (1.56) 2.24 (1.48) 2.00 (1.34)
4h 11.5 59.2 18.4 6.9 1.2 1.2 1.7 2.37 (1.08) 2.41 (1.35) 2.55 (1.60)
4i 55.8 20.1 6.3 10.9 3.5 2.9 0.6 1.97 (1.41) 1.68 (1.22) 1.75 (1.23)
4j 10.9 45.4 24.1 11.5 2.3 2.9 2.9 2.69 (1.32) 2.91 (1.93) 2.42 (1.73)
Note: Numbers in bold in the response category section indicate signiﬁcant ﬂoor or ceiling effect.
Abbreviation: DASS, Duke Anticoagulation Satisfaction Scale.
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Table 4 Results of the 3-factor analysis in our study cohort, in comparison to previously published studies
Our study (Maltese version) Our study (English version) Pelegrino et al13 (Brazilian-Portugues
version)
Samsa et al10 (English version)
Item Limitations Hassles/
burdens
Psychological
impact
Limitations Hassles/
burdens
Psychological
impact
Limitations Hassles/
burdens
Psychological
impact
Limitations Hassles/
burdens
Psychological
impact
1a 0.81 0.23 0.11 0.70 0.14 0.05 0.76 0.12 −0.09 0.68 0.34 −0.07
1b 0.75 0.14 −0.05 0.77 0.23 0.07 0.45 0.18 0.16 0.67 0.30 −0.04
1c 0.59 0.36 −0.29 0.43 0.21 −0.05 0.41 0.17 −0.38 0.50 0.09 −0.04
1d 0.86 0.13 −0.06 0.83 0.10 −0.07 0.56 0.13 −0.19 0.77 0.13 −0.12
1e 0.84 0.31 −0.04 0.84 0.24 −0.03 0.67 0.11 −0.04 0.81 0.31 −0.06
2a 0.19 0.35 −0.44 0.19 0.42 −0.05 0.24 0.13 −0.31 0.56 0.32 −0.16
2b 0.16 0.07 −0.43 0.18 0.38 −0.004 0.07 0.37 −0.19 0.43 −0.06 0.06
2c 0.28 0.41 −0.51 0.26 0.35 −0.14 0.18 0.38 −0.27 0.48 0.22 −0.04
2d 0.45 0.68 −0.19 0.36 0.59 0.02 0.47 0.39 0.03 0.75 0.41 −0.02
3a 0.33 0.61 −0.14 0.34 0.52 0.09 0.30 0.46 0.23 0.51 0.60 −0.01
3b 0.09 0.77 0.10 0.08 0.70 0.08 0.15 0.55 0.05 0.34 0.65 0.06
3c 0.32 0.73 −0.10 0.24 0.61 0.17 0.21 0.59 0.22 0.19 0.64 0.08
3d −0.22 0.58 0.34 −0.03 0.72 0.11 0.05 0.60 −0.06 0.26 0.71 −0.02
3e 0.14 0.85 0.16 0.04 0.83 0.17 0.05 0.71 0.15 0.12 0.81 0.00
3f 0.25 0.55 0.18 0.11 0.41 −0.03 0.10 0.63 0.07 0.27 0.44 −0.05
3g 0.10 0.84 0.09 0.04 0.86 0.06 0.04 0.74 0.08 0.20 0.77 0.06
3h 0.05 −0.04 0.39 −0.08 0.04 0.52 0.03 −0.07 0.43 0.04 −0.17 0.51
4a 0.10 0.15 0.40 0.02 0.05 0.72 −0.03 0.27 0.55 0.06 −0.06 0.76
4b 0.14 0.06 0.54 0.08 0.09 0.82 −0.11 0.16 0.62 0.01 0.11 0.83
4d 0.39 0.36 −0.005 0.31 0.35 0.06 0.41 0.17 −0.53 0.58 0.38 0.07
4f −0.14 −0.05 0.43 −0.05 −0.02 0.58 0.01 0.20 0.42 −0.25 −0.07 0.57
4g 0.26 0.50 −0.11 0.26 0.45 0.07 0.67 0.02 0.14 0.29 0.64 0.03
4h −0.05 0.14 0.34 0.06 0.30 0.63 0.09 0.20 0.72 −0.02 0.38 0.74
4i 0.23 0.57 −0.06 0.14 0.32 0.16 0.19 0.48 −0.07 0.07 0.68 0.06
4j −0.004 0.06 0.49 0.01 −0.005 0.61 0.22 −0.24 0.70 −0.15 0.20 0.70
Note: Numbers in bold indicate the highest loading of each factor, which is therefore likely to explore that dimension.
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observed poor results only in the latter. This ﬁnding sug-
gests that those patients who initially chose to complete
the Maltese version of the questionnaire were probably
less conﬁdent in English, in line with the hypothesis by
Chung et al.38
While ceiling effect was found only in one question, a
signiﬁcant ﬂoor effect was observed in both the Maltese
and the English versions in our study, as well as in the
original publication of the DASS,10 suggesting that it is
more likely to be an intrinsic characteristic of the ques-
tionnaire itself rather than a weakness of the Maltese
translation.
Results of the conﬁrmatory factor analysis were not
satisfactory: RMSEA and SRMR were slightly above the
acceptable limit; while GFI, AGFI and CFI were signiﬁ-
cantly below the acceptable cut-off. However, the ﬁt para-
meters were not reported in previous studies, making it
impossible to compare these results. Therefore, we per-
formed an additional exploratory factor analysis which
showed that the factors load on the three subscales was
similar to previous publications.10,13
Regarding construct validity, a signiﬁcant positive cor-
relation was found between the overall DASS score and its
subscales, in line with the fact that the DASS total score is
the sum of its three subscales (limitations, hassles and
burdens, and psychological impact).
For the known-group validity, both versions of the
DASS in our study correlated with sex and history of
bleeding. The Maltese version correlated also with antic-
oagulant treatment duration and hospitalization in the pre-
vious year, while the English version correlated also with
age and employment status. Differences in the study popu-
lation between patients who completed the Maltese and the
English version of the DASS might have contributed to
these slightly different results. Similarly, previous studies
reported that younger age10,13 and working status12,32 were
associated with lower satisfaction, suggesting that the bur-
den of anticoagulant therapy and INR monitoring is
greater for young working people, compared to older
retirees. In addition, hospitalization for bleeding correlated
with lower satisfaction in the studies by Samsa et al10 and
Radaideh et al.32 Although in our study we used two
different deﬁnitions (hospitalization in the previous year
and self-reported history of any bleeding), they showed the
same correlation with the DASS total score. Finally, higher
treatment satisfaction was reported by those patients on
VKA treatment for more than 5 years.
Anticoagulant therapy is the mainstay for the treatment of
VTE and for stroke prevention in patients with AF or mechan-
ical heart valves. In Malta around 1% of the population is
anticoagulated,39 corresponding to approximately 4000 peo-
ple. However, to the best of our knowledge, there was no
speciﬁc quality of life instrument for anticoagulated patients
that had been validated in theMaltese language. Assessing the
QoL is important in order to improve the quality of care for
anticoagulated patients. It has been shown that satisfaction
correlates with adherence and INR control40,41 and that, in
turn, the TTR correlates with thromboembolic and bleeding
complications.42 By identifying limitations and hassles asso-
ciated with VKA treatment, health care professionals can
provide speciﬁc educational interventions to improve the bur-
den associated with this treatment. Furthermore, they can also
Table 5 Correlation between satisfaction and sociodemographic or clinical characteristics
Variable Correlation coefﬁcient for DASS
total score for the Maltese version
(P-value)
Correlation coefﬁcient for DASS
total score for the English version
(P-value)
Increasing age −0.12 (0.12) −0.25 (0.002)
Sex: male −0.15 (0.05) −0.22 (0.004)
Living situation: living alone −0.02 (0.72) 0.06 (0.45)
Level of education: primary school only −0.05 (0.54) 0.01 (0.86)
Employment status: full- or part-time paid employment 0.09 (0.37) 0.17 (0.04)
Clinical indication to anticoagulation: atrial ﬁbrillation −0.09 (0.23) −0.08 (0.30)
Anticoagulant treatment duration: >5 years −0.18 (0.02) −0.05 (0.55)
INR in range at enrollment −0.06 (0.41) −0.01 (0.94)
High TTR (≥70%) in the previous year −0.01 (0.86) −0.05 (0.53)
Any hospitalization in the previous year 0.17 (0.03) 0.14 (0.09)
Self-reported history of any bleeding on warfarin 0.20 (0.01) 0.20 (0.01)
Note: Since lower DASS total scores represent greater satisfaction, a negative correlation means greater satisfaction.
Abbreviations: INR, international normalized ratio; TTR, time within therapeutic range; DASS, Duke Anticoagulation Satisfaction Scale.
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reinforce the positive aspects which are salient for each
patient. In our research project, we decided to translate the
DASS and the PACT-Q, because they are both psychometric
questionnaires that can be speciﬁcally used to assess the
quality of life of anticoagulated patients. Therefore, they
were administered at the same time to the same patients’
population (results of the validation of the PACT-Q2 are
reported elsewhere).20 The PACT-Q2 is shorter (20 questions
to be answered on a 5-point Likert scale), however the items of
the two dimensions “convenience” and “treatment satisfac-
tion” have to be scored separately. Conversely, the DASS is
slightly longer (25 questions to be answered on a 7-point scale)
but has the advantage that can provide one overall ﬁnal score.
The DASS was originally developed in the English10 and, so
far, it has been translated and validated in Greek,12 Brazilian-
Portuguese,13 Malay32 and Turkish.33 In our study, it was
translated inMaltese and tested in 157 patients who completed
the Maltese version and in 174 patients who completed the
English version. The availability of a large number of patients
enrolled from the same setting in a short time frame, who
completed the questionnaire in two different languages is a
peculiarity of our study. In fact, both English and Maltese are
ofﬁcial languages inMalta and it has been estimated that more
than two thirds of the population are bilingual,37 although
there is the prevalence of one language over the other in certain
areas (e.g., Maltese predominates as spoken language, while
English is mainly used in written communications).23 In our
study patients were enrolled from different locations around
theMaltese island, therefore our sample is likely to be general-
izable to the overall anticoagulated Maltese population.
Furthermore, although we included only patients on VKA, at
the time of enrollment the overwhelming majority of antic-
oagulated patients in Malta were on warfarin, since the novel
direct oral anticoagulants were not centrally funded.
The main strengths of our study are the completeness of
data (no missing answers) and the rigorous analysis to validate
the Maltese version of the DASS. Furthermore, a group of
patients in our study cohort completed the original English
version of the DASS, therefore allowing a comparison of the
psychometric properties of the two versions in the same
population.
However, our study has also some limitations which
need to be acknowledged. First, only patients on VKA
treatment were enrolled; therefore, our results might not
be generalizable to patients treated with other oral antic-
oagulants. Second, the number of patients included in the
test–retest was smaller than the generally recommended
size by Terwee et al29 for the calculation of the ICC.
Conclusion
The Maltese version of the DASS, administered to patients
receiving oral anticoagulation with VKA, showed good relia-
bility and an acceptable level of validity. These ﬁndings were
comparable to the original English version. The results of our
study suggest that the Maltese DASS is a valid and reliable
instrument to assess the level of satisfaction of Maltese-
speaking anticoagulated patients. It can be therefore used
by health care professionals working in the setting of antic-
oagulation clinics or in future research studies assessing
patients’ satisfaction and barriers to anticoagulant treatment.
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